16 | 4- imino- 1,3- diazabicyclo(3.1.0)hexan- 2- oneIBA
06/2016
-
01/2002 |
7 | Reactive Oxygen Species (Oxygen Radicals)IBA
06/2016
-
11/2006 |
6 | Sulfhydryl Compounds (Thiols)IBA
06/2016
-
01/2004 |
5 | Antineoplastic Agents (Antineoplastics)IBA
12/2013
-
11/2002 |
4 | Proteins (Proteins, Gene)FDA Link
04/2012
-
12/2002 |
3 | GemcitabineFDA Link
01/2015
-
07/2010 |
3 | Bortezomib (Velcade)FDA Link
06/2013
-
05/2005 |
2 | Contrast MediaIBA
06/2016
-
06/2012 |
2 | 5- (4- methoxyphenyl)- 2- (3- (3- methoxyphenyl)pyridin- 4- yl)oxazoleIBA
12/2013
-
11/2009 |
2 | OxazolesIBA
12/2013
-
11/2009 |
2 | Glutathione (Reduced Glutathione)IBA
06/2012
-
03/2012 |
2 | GlucocorticoidsIBA
05/2012
-
07/2006 |
2 | Doxorubicin (Adriamycin)FDA LinkGeneric
05/2012
-
07/2006 |
2 | Vincristine (Oncovin)FDA LinkGeneric
05/2012
-
07/2006 |
2 | Cyclophosphamide (Cytoxan)FDA LinkGeneric
05/2012
-
07/2006 |
2 | aziridine (ethyleneimine)IBA
07/2010
-
01/2002 |
2 | UA 62784IBA
11/2009
-
01/2009 |
2 | Mitoxantrone (Novantrone)FDA LinkGeneric
12/2007
-
06/2007 |
2 | 2- (2'- (dimethylamino)ethyl)- 1,2- dihydro- 7- ethoxydibenz(de,h)isoquinoline- 1,3- dioneIBA
12/2007
-
06/2007 |
2 | anthraceneIBA
12/2007
-
06/2007 |
2 | Type II DNA Topoisomerases (Topoisomerase II)IBA
06/2007
-
12/2002 |
2 | Proteasome InhibitorsIBA
05/2007
-
05/2005 |
1 | Biomarkers (Surrogate Marker)IBA
06/2016 |
1 | Histone Deacetylases (Histone Deacetylase)IBA
01/2015 |
1 | HeterochromatinIBA
01/2015 |
1 | Histone Deacetylase InhibitorsIBA
01/2015 |
1 | TubulinIBA
12/2013 |
1 | Nelfinavir (Viracept)FDA Link
06/2013 |
1 | HIV Protease InhibitorsIBA
06/2013 |
1 | 3-((4-benzylpiperazino)methyl)-1H-indoleIBA
06/2013 |
1 | CalpainIBA
06/2013 |
1 | CaspasesIBA
06/2013 |
1 | AlbuminsIBA
06/2012 |
1 | mercury orangeIBA
06/2012 |
1 | gadodiamide (Omniscan)FDA Link
06/2012 |
1 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
06/2012 |
1 | GadoliniumIBA
06/2012 |
1 | Buthionine SulfoximineIBA
06/2012 |
1 | EnzymesIBA
05/2012 |
1 | AntioxidantsIBA
05/2012 |
1 | AMP423IBA
04/2012 |
1 | Peptide Initiation Factors (Initiation Factor)IBA
03/2012 |
1 | Dacarbazine (DIC)FDA LinkGeneric
09/2011 |
1 | Drug CombinationsIBA
01/2011 |
1 | KinesinsIBA
11/2009 |
1 | Phosphotransferases (Kinase)IBA
11/2009 |
1 | Protein Kinases (Protein Kinase)IBA
11/2009 |
1 | tyrosine receptor (receptor, tyrosine)IBA
11/2009 |
1 | centromere protein EIBA
11/2009 |
1 | Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
11/2009 |
1 | terameprocolIBA
08/2009 |
1 | CarbonatesIBA
08/2009 |
1 | Sulfates (Sulfates, Inorganic)IBA
08/2009 |
1 | Acetates (Acetic Acid Esters)FDA Link
08/2009 |
1 | Masoprocol (Actinex)FDA Link
08/2009 |
1 | Oxygen (Dioxygen)IBA
02/2009 |
1 | Antimitotic AgentsIBA
01/2009 |
1 | perillyl alcoholIBA
01/2008 |
1 | Therapeutic UsesIBA
12/2007 |
1 | Immunosuppressive Agents (Immunosuppressants)IBA
12/2007 |
1 | IntegrinsIBA
11/2007 |
1 | Integrin alpha6IBA
11/2007 |
1 | quinone (benzoquinone)IBA
06/2007 |
1 | PoisonsIBA
06/2007 |
1 | hydroquinone (Esoterica)FDA Link
06/2007 |
1 | lissamine rhodamine B (sulforhodamine B)IBA
05/2007 |
1 | Dexamethasone (Maxidex)FDA LinkGeneric
05/2007 |
1 | thiazolyl blueIBA
05/2007 |
1 | EstersIBA
04/2007 |
1 | Diphosphonates (Bisphosphonates)IBA
04/2007 |
1 | apomine (SR 45023A)IBA
04/2007 |
1 | Caspase 3 (Caspase-3)IBA
04/2007 |